Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. QCOM
2. MU
3. CBRS
4. FDX
5. USO
6. HTZ
7. SPY
8. KBH
9. HON
10. JPM

Go back to Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs
(NASDAQ: NERV) Delayed: 4.33 -0.02 (0.46%)
Previous Close $4.35    52 Week High $15.84 
Open $4.33    52 Week Low $3.45 
Day High $4.53    P/E N/A 
Day Low $4.22    EPS $0.00 
Volume 131,131